Myriad Genetics, Inc. (MYGN)

NASDAQ: MYGN · Real-Time Price · USD

4.370

-0.130 (-2.89%)

At close: Feb 18, 2026, 4:00 PM EST

4.450

+0.080 (1.83%)

After-hours: Feb 18, 2026, 6:32 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Hereditary Cancers	327.80M
Hereditary Cancers Growth	7.30%
Prenatal	151.30M
Prenatal Growth	29.98%
Pharmacogenomics	138.50M
Pharmacogenomics Growth	8.54%
Tumor Profiling	135.60M
Tumor Profiling Growth	5.44%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
United States	671.70M
United States Growth	13.56%
Rest of World	81.50M
Rest of World Growth	-6.21%